Compared to normal lung and colon samples, GPR4 mRNA levels were increased by 2.3-fold (p = 3.04E-06) and 3.9-fold (p = 0.0074), respectively, in COVID-19 patient lung and colon samples. This evidence concerns the gene GPR4 and COVID-19.